Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

McKesson Corp (NY: MCK )

356.05 -1.73 (-0.48%)
Official Closing Price Updated: 7:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about McKesson Corp

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Analyst Expectations for McKesson's Future
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
 
Via Benzinga
This Foreboding Sign Looms Over McKesson's Chart
 
Via Benzinga
McKesson Corporation Announces Fourth-quarter Fiscal 2023 Earnings Release Date
From McKesson Corporation
Via Business Wire
Is It Too Late to Buy McKesson Stock?
The healthcare supplier has seen its shares climb 15% over the past year. 
Via The Motley Fool
How Is The Market Feeling About McKesson?
 
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,300 Today
 
Via Benzinga
McKesson Stock: Bull vs Bear
This healthcare stock trounced the S&P 500 last year. But is the case for McKesson still strong? 
Via The Motley Fool
Is McKesson a Buy?
McKesson's stock has significantly outperformed the S&P 500 over the past five years. 
Via The Motley Fool
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
These healthcare stocks to buy offer spectacular upside potential ahead in your defensive portfolio as we get deeper into 2023. 
Via InvestorPlace
If You Invested $5,000 in McKesson In 2020, This Is How Much You Would Have Today
McKesson is focusing on the growth areas of oncology and pharma services. 
Via The Motley Fool
Warren Buffett Just Sold Shares of This Company. Should You?
McKesson has offered investors safety and growth. 
Via The Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,300 Today
 
Via Benzinga
This Stock Could Fill Your Pockets for Years to Come
$273 billion in sales from a company you've probably never heard of. 
Via The Motley Fool
2 Best Buffett Stocks to Buy for the Long Haul
Warren Buffett is known for picking great businesses. 
Via The Motley Fool
McKesson Earnings Perspective: Return On Invested Capital
 
Via Benzinga
McKesson (MCK) Q3 2023 Earnings Call Transcript
MCK earnings call for the period ending December 31, 2022. 
Via The Motley Fool
$100 Invested In McKesson 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Analyst Expectations for McKesson's Future
 
Via Benzinga
3 Top Dividend Growth Stocks Billionaires Are Buying Hand Over Fist
Some of the world's most successful hedge fund managers are making big bets on these dividend payers. 
Via The Motley Fool
Is This Warren Buffett Stock a Buy for Dividend Growth Investors?
This Buffett-backed business leads the medical distribution industry. 
Via The Motley Fool
Warren Buffett Didn't Buy a Single New Stock to End 2022. But He Cut From 8.
Buffett's company Berkshire Hathaway spent more time selling stocks than buying in the fourth quarter of 2022. 
Via The Motley Fool
Warren Buffett Stocks: Berkshire Hathaway Loads Up on Apple, Flips Taiwan Semiconductor
Berkshire Hathaway trimmed bank holdings in Q4. 
Via Investor's Business Daily
3 Highly-Ranked Stocks That Beat The Market In 2022 To Buy Now
Today, we will dig into three highly-ranked stocks that outperformed the market in 2022 amid the turmoil and are primed to keep running higher in 2023, even if Wall Street is forced to take its foot... 
Via Talk Markets
McKesson Earnings Preview
 
Via Benzinga
McKesson Corporation Reports Fiscal 2023 Third-Quarter Results
From McKesson Corporation
Via Business Wire
7 Healthcare Stocks That Will Be Big Winners in 2023
Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider. 
Via InvestorPlace
McKesson Corporation Declares Quarterly Dividend
From McKesson Corporation
Via Business Wire
PYPL v CDNS: Are You Buying The Right Tech Stock?
Stock picking is a simple yet sophisticated art.  Simple tends to get misunderstood as easy, and the sophisticated part tends to get overlooked.  
Via Benzinga
Earnings Scheduled For February 1, 2023
Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.